Trial Profile

Pioglitazone influence of triglyceride accumulation in the myocardium in diabetes

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 19 Nov 2014

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Pioglitazone (Primary) ; Metformin
Indications Type 2 diabetes mellitus
Focus Pharmacodynamics
Acronyms PIRAMID

Most Recent Events

16 Sep 2011 Results of an analysis that focused on plasma omentin levels presented at the 47th Annual Meeting of the European Association for the Study of Diabetes.
29 Jun 2010 Effects of pioglitazone on plasma cholesteryl ester transfer protein (CETP) mass have been presented at the 70th Annual Scientific Sessions of the American Diabetes Association.
01 Jan 2010 Effects on pericardial fat volume have been published in the Journal of Clinical Endocrinology and Metabolism.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com